Cabazitaxel-d6
CAS: 1383561-29-2
Ref. 3D-IFC56129
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Product Information
Cabazitaxel-d6 is a cell permeable analog of cabazitaxel, which is a drug used to treat prostate cancer. Cabazitaxel-d6 has been shown to be a potent inhibitor of the TRPC1 ion channel and can be used as a research tool for pharmacology and protein interactions. This compound also has been shown to inhibit the production of inflammatory cytokines in macrophages. Cabazitaxel-d6 binds to the peptide sequence Arg-Leu-Arg-Ile-Lys in the TRPC1 receptor, which leads to inhibition of this ion channel. The binding causes an increase in intracellular calcium levels, which leads to apoptosis (cell death).
Chemical properties
Technical inquiry about: 3D-IFC56129 Cabazitaxel-d6
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.